Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03085108 · ClinicalTrials.gov registry record
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
A clinical trial, sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 130
- Enrollment target
NCT03085108: Completed study, sponsored by Janssen Scientific Affairs.
NCT03085108 is a clinical trial that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03085108 has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The main purpose of this cross-sectional study is to generate data to support the psychometric properties of the Suicide Ideation and Behavior Assessment Tool (SIBAT) and validate its use in participants at imminent risk of suicide.
Primary Outcome
The Clinical Global Impression - Severity of Suicidality - Revised (CGI-SS-R) was derived from the Clinical Global Impression Severity Scale (CGI-S), a global rating scale that gives an overall measure of the severity of a participants illness. The CGI-SS-R rating is scored on a 7-point scale from 0 (normal, not at all suicidal) to 6 (among the most extremely suicidal participants).
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2017-03-31 |
| Est. Completion | 2017-11-14 |
What the finished NCT03085108 record still lists
NCT03085108 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT03085108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03085108 about?
NCT03085108 is a clinical study titled "A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment". The main purpose of this cross-sectional study is to generate data to support the psychometric properties of the Suicide Ideation and Behavior Assessment Tool (SIBAT) and validate its use in participants at imminent risk of suicide.
What is the current status of trial NCT03085108?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2017-03-31. Estimated completion is 2017-11-14.
What interventions are being tested in trial NCT03085108?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT03085108?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI